List of Excipients in API bismuth subcitrate potassium, metronidazole, tetracycline hydrochloride
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing bismuth subcitrate potassium, metronidazole, tetracycline hydrochloride
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
Allergan Inc | PYLERA | bismuth subcitrate potassium, metronidazole, tetracycline hydrochloride | 58914-601 | GELATIN | |
Allergan Inc | PYLERA | bismuth subcitrate potassium, metronidazole, tetracycline hydrochloride | 58914-601 | LACTOSE MONOHYDRATE | |
Allergan Inc | PYLERA | bismuth subcitrate potassium, metronidazole, tetracycline hydrochloride | 58914-601 | MAGNESIUM STEARATE | |
Allergan Inc | PYLERA | bismuth subcitrate potassium, metronidazole, tetracycline hydrochloride | 58914-601 | TALC | |
Allergan Inc | PYLERA | bismuth subcitrate potassium, metronidazole, tetracycline hydrochloride | 58914-601 | TITANIUM DIOXIDE | |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing bismuth subcitrate potassium, metronidazole, tetracycline hydrochloride
Detailed excipient profiles for bismuth subcitrate potassium, metronidazole, tetracycline hydrochloride
Excipient focus: AMMONIA
bismuth subcitrate potassium, metronidazole, tetracycline hydrochloride drug variants containing AMMONIA
Company | Ingredient | NDC |
---|---|---|
Ingenus Pharmaceuticals LLC | bismuth subcitrate potassium, metronidazole, tetracycline hydrochloride | 50742-283 |
>Company | >Ingredient | >NDC |
bismuth subcitrate potassium, metronidazole, tetracycline hydrochloride drug variants not containing AMMONIA
Excipient focus: FERROSOFERRIC OXIDE
bismuth subcitrate potassium, metronidazole, tetracycline hydrochloride drug variants containing FERROSOFERRIC OXIDE
Company | Ingredient | NDC |
---|---|---|
Ingenus Pharmaceuticals LLC | bismuth subcitrate potassium, metronidazole, tetracycline hydrochloride | 50742-283 |
>Company | >Ingredient | >NDC |
bismuth subcitrate potassium, metronidazole, tetracycline hydrochloride drug variants not containing FERROSOFERRIC OXIDE
Excipient focus: GELATIN
bismuth subcitrate potassium, metronidazole, tetracycline hydrochloride drug variants containing GELATIN
bismuth subcitrate potassium, metronidazole, tetracycline hydrochloride drug variants not containing GELATIN
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
bismuth subcitrate potassium, metronidazole, tetracycline hydrochloride drug variants containing LACTOSE MONOHYDRATE
bismuth subcitrate potassium, metronidazole, tetracycline hydrochloride drug variants not containing LACTOSE MONOHYDRATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
bismuth subcitrate potassium, metronidazole, tetracycline hydrochloride drug variants containing MAGNESIUM STEARATE
bismuth subcitrate potassium, metronidazole, tetracycline hydrochloride drug variants not containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
bismuth subcitrate potassium, metronidazole, tetracycline hydrochloride drug variants containing PROPYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
Ingenus Pharmaceuticals LLC | bismuth subcitrate potassium, metronidazole, tetracycline hydrochloride | 50742-283 |
>Company | >Ingredient | >NDC |
bismuth subcitrate potassium, metronidazole, tetracycline hydrochloride drug variants not containing PROPYLENE GLYCOL
Excipient focus: SHELLAC
bismuth subcitrate potassium, metronidazole, tetracycline hydrochloride drug variants containing SHELLAC
Company | Ingredient | NDC |
---|---|---|
Ingenus Pharmaceuticals LLC | bismuth subcitrate potassium, metronidazole, tetracycline hydrochloride | 50742-283 |
>Company | >Ingredient | >NDC |
bismuth subcitrate potassium, metronidazole, tetracycline hydrochloride drug variants not containing SHELLAC
Excipient focus: TALC
bismuth subcitrate potassium, metronidazole, tetracycline hydrochloride drug variants containing TALC
bismuth subcitrate potassium, metronidazole, tetracycline hydrochloride drug variants not containing TALC
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
bismuth subcitrate potassium, metronidazole, tetracycline hydrochloride drug variants containing TITANIUM DIOXIDE
bismuth subcitrate potassium, metronidazole, tetracycline hydrochloride drug variants not containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.